February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix,…
From pandemic response to long-term community investment, TraceLink's corporate grants have supported 60 nonprofit organizations worldwideSummaryFrom 2020 through 2025, TraceLink's…
Grant Proceeds Will Accelerate Research Into Advanced Fiber-based Electronic Battery SystemsDALLAS, Jan. 20, 2026 /PRNewswire/ -- Solidion Technology Inc. ("Solidion" or…
January 16, 2026 16:05 ET | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”…
January 16, 2026 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.…
Grant Proceeds Will Accelerate Research Into Anti-Corrosive Additives in Molten-Salts-Based Heat Transfer Fluids For Nuclear Reactors.DALLAS, Dec. 29, 2025 /PRNewswire/…
Through this annual program, TraceLink champions global health equity, community resilience, and shared purposeSummaryTraceLink announced the eight global nonprofit recipients…
November 28, 2025 08:00 ET | Source: Spero Therapeutics, Inc. CAMBRIDGE, Mass., Nov. 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics,…
Grant Proceeds Will Accelerate Research and Commercialization of Electrochemical Manufacturing of High-Performance GraphiteDALLAS, Nov. 21, 2025 /PRNewswire/ -- Solidion Technology…
Company Announcement COPENHAGEN, Denmark; November 20, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided…